Skip to main content
Premium Trial:

Request an Annual Quote

Roche: Julie Brown

Roche announced that Julie Brown will be stepping down as a member of the board of directors, effective immediately, after accepting the CFO role at pharmaceutical company GSK, starting in May. Brown was elected to the board in March 2016 and has been the chairwoman of the audit committee since then. Patrick Frost will be the interim chair of the committee until the general meeting in March 2023. 

Brown currently serves as chief operating and financial officer at fashion firm Burberry. She was previously group CFO at medical technology company Smith and Nephew. Brown also held multiple roles at AstraZeneca, including interim group CFO and VP of group finance, regional commercial VP of Latin America, and VP of corporate strategy.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.